|
Video: What is a Stock Split?
|
|
AYTU BioPharma is a pharmaceutical company focused on commercializing therapeutics and consumer health products and developing therapeutics for pediatric-onset or difficult-to-treat diseases. Co. operates through two business segments: the BioPharma segment, consisting of prescription pharmaceutical products; and the Consumer Health segment, which consists of various consumer healthcare products. Co. also has two product candidates in development, AR101 (enzastaurin) for the treatment of vascular Ehlers-Danlos Syndrome and Healight (endotracheal ultraviolet light catheter) for the treatment of severe, difficult-to-treat respiratory infections. According to our AYTU split history records, AYTU BioPharma has had 3 splits. | |
|
AYTU BioPharma (AYTU) has 3 splits in our AYTU split history database. The first split for AYTU took place on August 13, 2018. This was a 1 for 20 reverse split, meaning for each 20 shares of AYTU owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split. AYTU's second split took place on December 09, 2020. This was a 1 for 10 reverse split, meaning for each 10 shares of AYTU owned pre-split, the shareholder now owned 1 share. For example, a 50 share position pre-split, became a 5 share position following the split. AYTU's third split took place on January 06, 2023. This was a 1 for 20 reverse split, meaning for each 20 shares of AYTU owned pre-split, the shareholder now owned 1 share. For example, a 5 share position pre-split, became a 0.25 share position following the split.
When a company such as AYTU BioPharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the AYTU split history from start to finish, an original position size of 1000 shares would have turned into 0.25 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AYTU BioPharma shares, starting with a $10,000 purchase of AYTU, presented on a split-history-adjusted basis factoring in the complete AYTU split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$2,000.00 |
|
End price/share: |
$3.04 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.85% |
|
Average Annual Total Return: |
-47.75% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$15.19 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
08/13/2018 | 1 for 20 | 12/09/2020 | 1 for 10 | 01/06/2023 | 1 for 20 |
|
|